GHK-Cu

GHK-Cu Dermatological & Tissue Overview

GHK-Cu initiates profound local changes to the dermal and epidermal architecture, shifting the cellular metabolism exclusively toward structural matrix generation and inflammatory reduction.

Physiochemical Diagnostics

Parameter	Value
Molecular Formula	C14H24N6O4•Cu
Molecular Mass	404.0 g/mol
Assay Purity	>99.0%
Appearance	Vibrant blue crystalline powder

Figure 1: Conceptual Action of GHK-Cu

In-Vivo Mechanism Cascade

Detailed transduction pattern yielding the cosmetic or regenerative property:

1. Functions as a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine.
2. Possesses a profound affinity for binding and transporting Copper(II) ions into the cellular matrix.
3. Upregulates the synthesis of collagen, elastin, and deep dermal proteoglycans.
4. Down-regulates the production of metalloproteinases, stopping the degradation of existing collagen.
5. Re-establishes the microcirculation (angiogenesis) within deeply damaged or aging dermal tissue.

Figure 2: Rate of Structural Deposition

Primary Research Results

• Outcome 1: Universally hailed as the absolute apex peptide for total dermatological, anti-aging rejuvenation.
• Outcome 2: Clinically proven to thicken aging skin, reduce fine lines, and physically shrink pore size.
• Outcome 3: Frequently utilized in extreme wound repair and hair follicle stimulation paradigms.

Gene Expression Remodeling & Skin Aging

GHK-Cu’s most remarkable property is its ability to modulate the expression of over 4,000 human genes—approximately 6% of the genome. Broad gene expression studies (Affymetrix microarrays) reveal that GHK-Cu resets gene activity patterns toward a healthier, younger profile. It upregulates genes involved in antioxidant defense, DNA repair, ubiquitin-proteasome activity (cellular waste removal), and stem cell maintenance, while simultaneously downregulating genes associated with inflammation, fibrosis, and tissue destruction. No other single compound has demonstrated such a wide-ranging transcriptomic effect.

1. GHK-Cu upregulates 31 collagen-related genes and 5 elastin-related genes, directly rebuilding the dermal structural matrix.
2. Decorin expression increases, which organizes collagen fibrils into properly spaced arrays and antagonizes TGF-β-mediated scarring.
3. Superoxide dismutase (SOD1, SOD3) and glutathione-related gene expression rises, strengthening the antioxidant shield against UV-induced ROS.
4. VEGF and FGF2 are upregulated, improving dermal microcirculation and nutrient delivery to the epidermal basal layer.
5. Metalloproteinase inhibitors (TIMP-1, TIMP-2) are induced while destructive MMPs (MMP-2, MMP-9) are suppressed, protecting against enzymatic collagen degradation.

Research-Grade Injectable vs. Cosmetic Use

• Injectable Format: This vial format is supplied as a lyophilized research-grade peptide for subcutaneous or mesotherapy-style research, delivering GHK-Cu systemically or to targeted dermal zones.
• Concentration: Typical research reconstitution yields 1–5 mg/mL solutions for localized injection protocols.
• Hair Research: Subcutaneous GHK-Cu administration near follicular sites has shown enlargement of hair follicle size comparable to minoxidil in rodent models.
• Wound Healing: Injectable GHK-Cu accelerates wound contraction, re-epithelialization, and neovascularization in full-thickness wound models.
• Age-Related Decline: Plasma GHK-Cu concentration declines from ~200 ng/mL at age 20 to ~80 ng/mL by age 60, correlating with visible skin aging milestones.